Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells.

Tecimer T, Dlott J, Chuntharapai A, Martin AW, Peiper SC.

Arch Pathol Lab Med. 2000 Apr;124(4):520-5.

PMID:
10747307
2.

ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.

Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M.

Pharmacol Ther. 2006 Oct;112(1):139-49. Epub 2006 May 23. Review.

PMID:
16720046
3.

Neutrophil receptors for interleukin-8 and related CXC chemokines.

Murphy PM.

Semin Hematol. 1997 Oct;34(4):311-8. Review.

PMID:
9347581
4.

The molecular basis of selectivity between CC and CXC chemokines: the possibility of chemokine antagonists as anti-inflammatory agents.

Wells TN, Lusti-Narasimhan M, Chung CW, Cooke R, Power CA, Peitsch MC, Proudfoot AE.

Ann N Y Acad Sci. 1996 Oct 31;796:245-56. Review. No abstract available.

PMID:
8906232
5.

Classification of normal and neoplastic neuroendocrine cells.

Klöppel G, Heitz PU.

Ann N Y Acad Sci. 1994 Sep 15;733:19-23. Review. No abstract available.

PMID:
7978867
6.

Interleukin-8 and its receptor CXCR2 in atherosclerosis.

Boisvert WA, Curtiss LK, Terkeltaub RA.

Immunol Res. 2000;21(2-3):129-37. Review.

PMID:
10852110
7.

[Neuroendocrine cells of the respiratory system and neuroendocrine cancers of the lung].

Rowińska-Zakrzewska E.

Pneumonol Alergol Pol. 1995;63(1-2):99-103. Review. Polish. No abstract available.

PMID:
7633379
8.

Neuroendocrine influences on cancer progression.

Armaiz-Pena GN, Cole SW, Lutgendorf SK, Sood AK.

Brain Behav Immun. 2013 Mar;30 Suppl:S19-25. doi: 10.1016/j.bbi.2012.06.005. Epub 2012 Jun 21. Review.

Supplemental Content

Support Center